Immunodiagnostics market is expected to garner $17,836 Million by 2022, registering a CAGR of 7.3% during the forecast period 2016-2022. Immunodiagnostics is the branch of in vitro diagnostics that deals with the diagnosis of several diseases on the basis of antigen antibody reaction.

Portland, OR -- (SBWire) -- 03/15/2018 --Its a primary means for diagnosing infectious disease, chronic diseases such as cancer and cardiovascular diseases, autoimmunity diseases, and endocrinology among others. The significant advancement in the immunodiagnostics technologies have enhanced the ability to target the areas to diagnose disease progression. The growth in development has improved the diagnosis of complex diseases. The immunodiagnostics market is segmented based on product type into reagents, instruments, and software & services.

The rise in incidences of infectious diseases (HIV, STI, hepatitis B, and others), cardiovascular diseases, cancer, gastrointestinal, and other chronic diseases across the world owing to the growth in aged population and changes in demographics & lifestyle are the major factors to drive the growth of the immunodiagnostics market. In addition, technological advancement in diagnosis kits, assays and analyzers and increase in awareness of the preventive health measures among the patients and medical professionals further stimulate the demand for immunodiagnostics products thus boosting the growth.

Get the PDF of Immunodiagnostics industry insights @ https://www.alliedmarketresearch.com/request-sample/1763

The rise in incidences of infectious diseases (HIV, STI, hepatitis B, and others), cardiovascular diseases, cancer, gastrointestinal, and other chronic diseases across the world owing to the growth in aged population and changes in demographics & lifestyle are the major factors to drive the growth of the immunodiagnostics market. In addition, technological advancement in diagnosis kits, assays and analyzers and increase in awareness of the preventive health measures among the patients and medical professionals further stimulate the demand for immunodiagnostics products thus boosting the growth.

Immunodiagnostics has various other end users such as contract research organizations (CROs), blood banks, local public health laboratories, community clinics, home health agencies, nursing homes, and ambulatory surgical services and centers.

Do purchase inquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/1763

Abbott Laboratories, Immunodiagnostic Systems Holdings Plc (IDS), DiaSorin S.p.A., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Siemens AG, Sysmex Corporation, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., and Arkray, Inc. are the key players that operate in the global immunodiagnostics market.

Other players in the value chain include Arkray, Inc., Alere, Inc., Merck Millipore, Becton, Dickinson and Company, Biomerieux SA, Medicaroid Corporation, Qiagen NV, Affimetrix, ImmunoDX, Meridian Bioscience and others.

Immunodiagnostics Market Key Benefits

- The study provides an in-depth analysis of the global immunodiagnostics market with current trends and future estimations to elucidate the imminent investment pockets.
- The report provides a quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities.
- Competitive intelligence highlights the business practices followed by leading market players across various geographic regions.
- Porters Five Forces model will interpret the bargaining power of suppliers and buyers, threat of new entrants and substitutes, and competition amongst the key players.
- Extensive analysis is conducted by following key product positioning and monitoring the top competitors within the market framework.